Erythrocytes: member of the immune system that should not be ignored
Retatrutide achieved up to 24.2% body weight reduction over 48 weeks in the Phase 2 trial published in the New England Journal of Medicine , which involved adults with obesity but without diabetes
You may qualify if: BMI 27 with a medical condition BMI 30 Struggling with insulin resistance or PCOS Failed diet/exercise alone
We want you to feel capable, motivated, and equipped to take on whatever challenge is next on your list
Thus, eating smaller portions spread throughout the day gives your gut less to process at once, which may reduce both constipation and diarrhea
MASLD Substudy Sanyal et al., Nature Medicine (2024) Sanyal and colleagues conducted a prespecified phase 2a substudy of the original phase 2 obesity trial, evaluating retatrutide in participants with metabolic dysfunction-associated steatotic liver disease (MASLD)